We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.68B
AUM Growth
+$4.27B
Cap. Flow
+$4.13B
Cap. Flow %
61.82%
Top 10 Hldgs %
13.41%
Holding
935
New
392
Increased
185
Reduced
81
Closed
253

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$84.6M
2
MCD icon
McDonald's
MCD
+$79.3M
3
BBY icon
Best Buy
BBY
+$78M
4
SPGI icon
S&P Global
SPGI
+$75.1M
5
DGX icon
Quest Diagnostics
DGX
+$73.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.81%
2 Healthcare 17.75%
3 Technology 12.65%
4 Financials 8.92%
5 Consumer Staples 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
1
Zoetis
ZTS
$31.3B
$155M 2.32%
1,823,176
+701,801
+63% +$59.2M
BBY icon
2
Best Buy
BBY
$17.8B
$96M 1.44%
1,287,293
+1,055,122
+454% +$78M
ATVI
3
DELISTED
Activision Blizzard
ATVI
$92.8M 1.39%
1,216,280
+1,027,904
+546% +$72.7M
TFX icon
4
Teleflex
TFX
$5.81B
$91.9M 1.38%
342,631
+315,814
+1,178% +$84.6M
DGX icon
5
Quest Diagnostics
DGX
$25.2B
$81.8M 1.22%
743,856
+706,933
+1,915% +$73.6M
MCD icon
6
McDonald's
MCD
$187B
$79.6M 1.19%
507,719
+489,361
+2,666% +$79.3M
SPGI icon
7
S&P Global
SPGI
$124B
$79.5M 1.19%
389,800
+380,258
+3,985% +$75.1M
EA icon
8
Electronic Arts
EA
$52.4B
$75.5M 1.13%
535,578
+76,988
+17% +$10M
WUBA
9
DELISTED
58.com Inc
WUBA
$73.4M 1.1%
1,058,141
+528,249
+100% +$43.1M
BURL icon
10
Burlington
BURL
$21.4B
$70.3M 1.05%
467,347
+461,041
+7,311% +$65.6M
MSFT icon
11
Microsoft
MSFT
$2.83T
$68.4M 1.02%
694,108
+476,908
+220% +$46.2M
ROST icon
12
Ross Stores
ROST
$74.5B
$66.9M 1%
789,183
+767,357
+3,516% +$62.5M
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$120B
$64M 0.96%
376,485
+343,094
+1,028% +$53.2M
TMUS icon
14
T-Mobile US
TMUS
$184B
$62.6M 0.94%
+1,047,593
New +$62M
AZO icon
15
AutoZone
AZO
$47.7B
$62.3M 0.93%
92,853
+83,312
+873% +$53.8M
BSX icon
16
Boston Scientific
BSX
$64.8B
$61.3M 0.92%
1,873,361
+1,751,500
+1,437% +$52.8M
A icon
17
Agilent Technologies
A
$39.5B
$60.7M 0.91%
981,142
+930,356
+1,832% +$60.7M
USFD icon
18
US Foods
USFD
$21B
$60.5M 0.91%
1,600,465
+609,680
+62% +$21.6M
SHPG
19
DELISTED
Shire pic
SHPG
$60.1M 0.9%
356,002
+89,769
+34% +$14.5M
AXGN icon
20
Axogen
AXGN
$2.11B
$58.7M 0.88%
+1,168,953
New +$51.5M
TSM icon
21
TSMC
TSM
$2.16T
$58.4M 0.87%
+1,597,877
New +$63.1M
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$3.88T
$54.1M 0.81%
958,100
+886,980
+1,247% +$48.2M
PM icon
23
Philip Morris
PM
$298B
$54.1M 0.81%
669,634
+653,584
+4,072% +$55.5M
SINA
24
DELISTED
Sina Corp
SINA
$52.3M 0.78%
618,076
+536,640
+659% +$49.9M
COST icon
25
Costco
COST
$411B
$52.3M 0.78%
250,388
+235,505
+1,582% +$46.5M

Similar funds

Marshall Wace's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace held 935 positions worth $6.68B, up 177% from $2.41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.13B of net new capital in Q2 2018, opening 392 new positions and adding to 185 existing holdings. Its largest new stake was TSMC: 1,597,877 shares worth $58.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alibaba, an estimated $79.1M trimmed.

  • Marshall Wace's largest Q2 2018 buy was TSMC: 1,597,877 shares worth $58.4M.
  • Marshall Wace added most to Teleflex in Q2 2018, an estimated $84.6M increase.
  • Marshall Wace's biggest Q2 2018 reduction was Alibaba, cutting an estimated $79.1M.
  • Marshall Wace fully exited Monsanto Co in Q2 2018, selling an estimated $59.9M.
  • Marshall Wace's ten largest holdings make up 13% of its $6.68B portfolio in Q2 2018.
  • Marshall Wace opened 392 new positions and closed 253 in Q2 2018.
  • Marshall Wace's portfolio value rose 177% quarter-over-quarter to $6.68B.

Based on Marshall Wace's 13F filing for Q2 2018, filed 14 Aug 2018.